Public drug program spending in Canada by top drug classes 2022
This statistic shows the top 10 drug classes in Canada based on share of total public drug program spending in 2022. In that year, 1.9 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
